Heartflow, Inc.’s (NASDAQ:HTFL) Lock-Up Period Will End on February 4th

Heartflow’s (NASDAQ:HTFL) lock-up period is set to expire on Wednesday, February 4th. Heartflow had issued 16,666,667 shares in its initial public offering on August 8th. The total size of the offering was $316,666,673 based on an initial share price of $19.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Wells Fargo & Company began coverage on Heartflow in a research report on Wednesday. They issued an “overweight” rating and a $38.00 price objective for the company. Stifel Nicolaus increased their price target on Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Canaccord Genuity Group raised their price target on Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a report on Thursday, November 13th. Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Five research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $38.50.

Heartflow Trading Down 3.1%

Heartflow stock opened at $29.87 on Friday. The company’s 50-day moving average price is $30.71. The stock has a market cap of $2.54 billion and a P/E ratio of -16.50. Heartflow has a fifty-two week low of $25.38 and a fifty-two week high of $41.22.

Insiders Place Their Bets

In related news, Director Jeffrey C. Lightcap purchased 40,000 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was acquired at an average cost of $26.34 per share, for a total transaction of $1,053,600.00. Following the completion of the transaction, the director directly owned 40,000 shares in the company, valued at approximately $1,053,600. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Institutional Trading of Heartflow

Several institutional investors have recently added to or reduced their stakes in the stock. TFC Financial Management Inc. purchased a new stake in shares of Heartflow in the 3rd quarter valued at $40,000. Legal & General Group Plc acquired a new position in shares of Heartflow in the third quarter valued at approximately $59,000. Y Intercept Hong Kong Ltd purchased a new stake in Heartflow during the 3rd quarter worth approximately $234,000. Legato Capital Management LLC acquired a new stake in Heartflow during the 3rd quarter worth approximately $243,000. Finally, Sandia Investment Management LP purchased a new position in Heartflow in the 3rd quarter valued at approximately $252,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.